PTA-News: Biofrontera AG: Biofrontera reports results for the first half of 2026

Biofrontera AGby Investor RelationsBusiness news for the stock market Leverkusen (pta/30.09.2026/13:30) - Leverkusen, September 30, 2026 — Biofrontera AG (ISIN: DE000A4BGGM7), an international biopharmaceutical company specialized in dermatology, today announced its financial results for the first…